DNA Methylation Market, Global Outlook and Forecast 2024-2030
DNA methylation is an epigenetic mechanism that occurs by the addition of a methyl (CH3) group to DNA, thereby often modifying the function of the genes and affecting gene expression. The most widely characterized DNA methylation process is the covalent addition of the methyl group at the 5-carbon of the cytosine ring resulting in 5-methylcytosine (5-mC), also informally known as the ?fifth base? of DNA. These methyl groups project into the major groove of DNA and inhibit transcription.
This report contains market size and forecasts of DNA Methylation in Global, including the following market information:
Global DNA Methylation Market Size 2025-2030, ($ millions)
The global DNA Methylation market is projected to reach US$ million by 2030.
We surveyed the DNA Methylation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DNA Methylation Market, by Type, 2025-2030 ($ millions)
Global DNA Methylation Market Segment Percentages, by Type
Consumables
Instruments
Software Tools
Global DNA Methylation Market, by Application, 2025-2030 ($ millions)
Global DNA Methylation Market Segment Percentages, by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)
Others
Global DNA Methylation Market, By Region and Country, 2025-2030 ($ Millions)
Global DNA Methylation Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Abcam plc
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Exact Sciences Corporation
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Merck Group
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Active Motif, Inc.
Diagenode Diagnostics SA
EpiGentek Group Inc.
New England Biolabs, Inc.
Zymo Research Corporation
